Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Niacinamide + retinol is a synergistic topical combination widely utilized in dermatology and cosmeceuticals for the management of photoaging, acne, and hyperpigmentation. Retinol, a precursor to retinoic acid, acts as a retinoic acid receptor (RAR) agonist, promoting keratinocyte proliferation, enhancing epidermal thickness, and stimulating collagen synthesis. However, its use is frequently limited by 'retinization,' a period of skin irritation characterized by erythema and dryness. Niacinamide (vitamin B3) serves as a precursor to the cofactors NAD+ and NADP+, which are essential for cellular energy metabolism and DNA repair. Niacinamide enhances the skin's barrier function by increasing the synthesis of ceramides and other stratum corneum lipids, while also providing potent anti-inflammatory effects. When formulated together, niacinamide mitigates the irritant potential of retinol, improving patient tolerability and overall therapeutic efficacy in improving skin texture and tone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on niacinamide + retinol.